<--GAT-->
Clinical Topics

Algorithm Proposed to Improve Detection of MS Lesions

by U.S. Medicine

September 4, 2018

PHILADELPHIA—Magnetic resonance imaging (MRI) is considered crucial for in vivo detection and characterization of white matter lesions (WMLs) in multiple sclerosis.

Despite research on WMLs for at least the last 20 years using MRI, a report in the Journal of Neuroimaging noted that automated segmentation remains challenging.

“Although the majority of statistical techniques for the automated segmentation of WMLs are based on single imaging modalities, recent advances have used multimodal techniques for identifying WMLs,” wrote study authors led by University of Pennsylvania Perelman School of Medicine researchers and including participation from the Henry M. Jackson Foundation for the Advancement of Military Medicine. “Complementary modalities emphasize different tissue properties, which help identify interrelated features of lesions.

The study team proposed the Method for Inter-Modal Segmentation Analysis (MIMoSA), a fully automatic lesion segmentation algorithm that utilizes novel covariance features from intermodal coupling regression in addition to mean structure to model the probability lesion is contained in each voxel.

Using two datasets, the MIMoSA algorithm was validated by comparison with both expert manual and other automated segmentation methods. In the first at Johns Hopkins Hospital, in two datasets, bootstrap cross-validation was used to compare the performance of MIMoSA against OASIS and LesionTOADS, two popular automatic segmentation approaches, in 98 subjects. Publicly-available data from a segmentation challenge were used for performance benchmarking as a secondary validation, the authors stated.

Results of the Johns Hopkins study indicated that MIMoSA yielded average Sørensen-Dice coefficient (DSC) of 0.57 and partial AUC of 0.68 calculated with false positive rates up to 1%. In addition to being superior to performance using OASIS and LesionTOADS, the proposed method also performed competitively in the segmentation challenge dataset, researchers wrote.

“MIMoSA resulted in statistically significant improvements in lesion segmentation performance compared with LesionTOADS and OASIS and performed competitively in an additional validation study,” study authors concluded.

1. Valcarcel AM, Linn KA, Vandekar SN, Satterthwaite TD, Muschelli J, Calabresi PA, Pham DL, Martin ML, Shinohara RT. MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions. J Neuroimaging. 2018 Jul;28(4):389-398. doi: 10.1111/jon.12506. Epub 2018 Mar 8. PubMed PMID: 29516669; PubMed Central PMCID: PMC6030441.


Comments are closed here.


Related Articles

Administrative Confusions Results in Little Oversight of VA’s Police Force

Suicides, Violence at VMACs Put Spotlight on Security WASHINGTON—As the number of suicides and other violent incidents at VA facilities grows, a spotlight is being thrown on VA’s internal police force and its ability to... View Article

All VA Healthcare Facilities to Be Completely Smoke-Free by October

New Directive Abolishes Designated Smoking Zones WASHINGTON—Starting in October, all VA healthcare facilities will be official no-smoking zones. While VA now permits smoking in designated areas, the department has issued a new policy restricting smoking... View Article


U.S. Medicine Recommends


More From neurology

Neurology

Veterans With PNES Have Lower QoL vs. Other Seizures

PORTLAND, OR—Do seizure disorders affect veterans differently than patients who have never been in the U.S. military? And does the type of seizure matter? A study published in Epilepsy & Behavior examined those issues.1  VA... View Article

Neurology

Higher Efficacy DMTs Reduce MS Brain Atrophy

BETHESDA, MD—How do disease-modifying therapies (DMTs) affect region-specific brain atrophy in multiple sclerosis? A recent study sought to answer that question. Researchers from the Center for Neuroscience and Regenerative Medicine, at The Henry M. Jackson... View Article

Alzheimer's/Dementia

TBI Might Not Be a Risk Factor for Alzheimer’s Disease

BOSTON—New research is calling into question whether traumatic brain injury is actually a risk factor for Alzheimer’s disease. A report in the journal Alzheimer’s & Dementia discussed recent research with neuropathologic or biomarker evidence of... View Article

Neurology

Physical Fitness Associated With Lower Parkinson’s Rates

While exercise is important physical therapy for Parkinson's disease, it might be more than that.

Neurology

Increasing Usage of SSRIs for Dementia Symptoms

Emerging data has suggested effectiveness for selective serotonin reuptake inhibitors for treatment of behavioral and psychological symptoms of dementia.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up